Title : Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis.

Pub. Date : 2021 Jan 22

PMID : 33385109






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Boosting NAD+ via genetic or pharmacological CD38 targeting or NAD+ precursor supplementation protected mice from skin, lung, and peritoneal fibrosis. NAD CD38 antigen Mus musculus
2 In mechanistic experiments, CD38 was found to reduce NAD+ levels and sirtuin activity to augment cellular fibrotic responses, while inhibiting CD38 had the opposite effect. NAD CD38 antigen Mus musculus
3 Thus, we identify CD38 upregulation and resulting disrupted NAD+ homeostasis as a fundamental mechanism driving fibrosis in SSc, suggesting that CD38 might represent a novel therapeutic target. NAD CD38 antigen Mus musculus
4 Thus, we identify CD38 upregulation and resulting disrupted NAD+ homeostasis as a fundamental mechanism driving fibrosis in SSc, suggesting that CD38 might represent a novel therapeutic target. NAD CD38 antigen Mus musculus